Taoiseach Micheál Martin is due to meet US President Donald Trump later today in a hotly anticipated meeting as part of St ...

Revenue of our innovative products getting traction, so AUSTEDO as you can see, we've consistently executed that and finished ... effective pharmaceutical medicines to the U.S. market, which ...

84%) are intermediary goods shipped to the US to be finished in US factories, by US workers, thereby adding value to the US economy.” A spokesperson for the Irish Pharmaceutical Healthcare ...

The pharmaceutical industry faces significantly longer lead times than other industries, and time delays can seriously impact the health outcomes of countless individuals. Recognizing the potential ...

most big European exports to the US are more industrial — think finished manufactured goods like pharmaceutical products, machinery, and autos. Just this morning, another maker of luxury goods ...

Generic drugmakers and hospital pharmacists warn that added financial pressure from tariffs could strain the nation's generic drug supplies.

Deborah Golden, Deloitte's US chief innovation officer, said these advancements were poised to change which skills the pharmaceutical industry prioritizes in recruitment. Biology and chemistry ...

These high-yield dividend stocks are outstanding ideas for growth and income investors now, as they hold up better during a ...

Ireland's foreign investment agency says just 16% of Irish pharmaceutical exports are finished products and around 75% of Ireland's multinational produced goods are exported to international ...

By contrast, Trump's first two rounds of punitive tariffs on Chinese industrial goods in 2018 during his ... in the construction industry in particular, and automotive." Ujczo, senior counsel ...

The UK PM Society’s Market Access Interest Group (MAIG) undertook a comprehensive survey on the topic of market access, where it sought the views of both industry and agency. The answers were ...

China’s growing influence on pharmaceutical research and development represents a significant wildcard for the industry in 2025. The country’s clinical trial landscape continues to expand ...